Robert Lechleider, Chief Medical Officer at Immunome Inc. (IMNM), sold 55,000 shares at $21.95 ($1.2M) on 2026-07-02, disclosed to the SEC on 2026-07-07.
Scheduled sale ($1.2M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.95 | 22,714 | $499K | 40.1% |
| 2 | $22.76 | 16,214 | $369K | 29.7% |
| 3 | $23.44 | 16,072 | $377K | 30.3% |
| Total | $22.62 avg | 55,000 | $1.2M | 100% |
| Filing → |